Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)

Status:

Recruiting

III

Phase

3rd

Line of Therapy

Advanced / Metastatic

Disease Stage

Biomarker(s)

Investigational

Product

[Lu-177]-PNT2002

Treatment Arms

o Experimental: [Lu-177]-PNT2002 (Arm A)

o Active Comparator:
Control Arm (Arm B)